A few years ago, home sample collection was a premium add-on. Today it is an expectation. A patient books online, a phlebotomist arrives on a scooter, a tube of blood is drawn at a dining table, and a report appears on a phone that evening. It feels seamless from the outside. From the inside — if you run the lab — it is the part of your operation most likely to be losing money and traceability at the same time, precisely because it looks so simple.
Home collection is a logistics business your lab accidentally started
The instant you offered doorstep collection, you stopped being purely a diagnostics business and started being a logistics one as well. You now schedule people across a city, route them between appointments, manage the time between a draw and the sample reaching the analyser, and account for cash or UPI collected in a hundred living rooms. Most labs bolted this on without changing a single thing about how they measure it. The result is a service that patients love and owners cannot explain the margin on.
The economics nobody costs properly
- Phlebotomist time and travel per visit — the true cost of a home draw is the salary slice plus the scooter, not just the collection fee.
- Single low-value tests collected at home that cost more to fetch than they will ever bill.
- No-shows, wrong addresses and re-visits, each one a fully-loaded cost with zero revenue.
- Cash and UPI collected at the door that has to reconcile, patient by patient, against what was actually booked.
- Health packages priced as a bundle, where one loss-making home visit can quietly erase the margin on the whole package.
None of this means home collection is a bad idea — it is a genuinely good one. It means home collection has to be measured like the logistics operation it is, so you know which routes, which packages and which pin codes actually make money, and which ones you are subsidising out of habit.
Chain-of-custody: the sample that arrives unlabelled
The most expensive failure in home collection is not economic, it is clinical. A sample should be barcoded and tied to the patient at the doorstep, at the moment of the draw — not re-labelled back at the lab from a slip of paper. Every time patient details are re-keyed between the booking, the collection and the analyser, you introduce a chance to swap a name, transpose a digit, or attach a result to the wrong person. In diagnostics, a mislabelled tube is not an admin error to be cleaned up later; it is a wrong report that a doctor may act on. A clean chain-of-custody — one identity, barcoded once, carried untouched from home to result to report — is the difference between a service you can defend and one you are quietly lucky with.
Billing that stays clean — and exempt where it should be
Here is a fact many lab owners are unsure about: health care services by a clinical establishment, which includes diagnostic and pathology services, are exempt from GST under Entry 74 of Notification 12/2017-Central Tax (Rate). So your core test menu is not something you charge GST on. But the picture is not uniformly exempt, and that is where invoices go wrong. The consumables, reagents and equipment you buy still carry GST as an input cost you cannot pass on. Non-diagnostic extras — certain wellness or convenience add-ons — may not enjoy the same exemption. A billing system that knows which line is exempt healthcare and which is not keeps you clean on both sides: you do not wrongly charge tax on an exempt test, and you do not quietly under-account where tax genuinely applies.
ABDM and the Health Facility Registry
The Ayushman Bharat Digital Mission is steadily becoming the plumbing of Indian healthcare. Registering your lab on the Health Facility Registry, linking reports to a patient's ABHA, and letting results flow into their digital health record is moving from nice-to-have toward expected — and a home-collection report should ride the same rails as a walk-in one. Building this in now, rather than retrofitting it under pressure later, is the cheaper path.
In diagnostics, the sample is the product. If you cannot prove whose it is and where it has been, nothing downstream can be trusted.
CrelioHealth — and the single-centre reality
CrelioHealth is a genuinely strong laboratory platform, and this is not a swipe at it. It is a mature LIMS with deep features, and for a multi-centre lab network with the scale and the team to use all of it, it earns its place. The honest question for a single-centre or small-network lab is whether you need — and want to pay for — that full weight. A premium platform priced and designed around large networks can be more system than a two-doctor collection centre can absorb, and paying for capability you never switch on is its own kind of waste. Fair product, real strengths, sometimes the wrong size.
How BizRevolt fits a single-centre lab
BizRevolt's diagnostics workspace runs the whole chain for a single centre or a small network: online and home-collection booking, barcoding at the point of draw, order to result to report with no re-keying, and reports that are ready to flow to ABHA. Health packages can run on UPI AutoPay so recurring wellness revenue is not a manual chase. Referring-doctor attribution is built in so you know which relationships actually drive volume. And billing keeps the exempt and non-exempt lines straight. It is priced for a real lab, not an enterprise rollout.
- Lab — ₹999/month: single centre — bookings, home collection, barcoded chain-of-custody, order-to-report and GST-clean billing.
- Growth — ₹2,499/month: collection-centre network, referring-doctor commissions, packages on AutoPay and ABDM-ready reporting.
If you cannot say today which of your home-collection routes make money and which lose it, that is the number worth finding before you add another phlebotomist. We are building this alongside single-centre labs that do their own home collection, and we would rather see your actual workflow than assume it. Message or call the founder directly on +91 91 0657 4865, and we will trace one sample end to end with you.